Oncotelic Therapeutics annual operating margin
2012
2013
2020
2023
Oncotelic Therapeutics Operating Margin Growth & History (OTLC)
Oncotelic Therapeutics's operating margin was −9,497.16% for fiscal 2023.
View full Oncotelic Therapeutics company overviewOncotelic Therapeutics annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2023 | 2023-12-31 | −9,497.16% | −9061.47 pp |
| 2020 | 2020-12-31 | −435.69% | +8280.10 pp |
| 2013 | 2013-12-31 | −8,715.79% | −3541.43 pp |
| 2012 | 2012-12-31 | −5,174.36% | — |
Oncotelic Therapeutics quarterly operating margin
Q1.12
Q4.12
Q3.13
Q1.20
Q2.20
Q3.20
Q3.23
Q2.26
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −337.43% | +439.63 pp |
| Q3 2023 | 2023-09-30 | 20.68% | +2807.00 pp |
| Q3 2020 | 2020-09-30 | −115.45% | +3863.12 pp |
| Q2 2020 | 2020-06-30 | 0.99% | +1654.50 pp |
| Q1 2020 | 2020-03-31 | −777.06% | — |
| Q3 2013 | 2013-09-30 | −2,786.32% | — |
| Q4 2012 | 2012-12-31 | −3,978.57% | — |
| Q1 2012 | 2012-03-31 | −1,653.51% | — |
Oncotelic Therapeutics operating margin trends
Across the available reported history, Oncotelic Therapeutics's operating margin decreased from −435.69% to −9,497.16%, a change of −9061.47 percentage points. The latest reported quarter, Q2 2026, shows −337.43%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Oncotelic Therapeutics filings at SEC.gov ↗